UK-based consumer health player Venture Life Group has expanded its product portfolio and broadened its reach in Europe with the acquisition of Pharma Source BV for an initial €5.23m ($5.81m), plus a deferred contingent consideration of up to €1.27m.
Netherlands-based development and distribution firm Pharma Source markets a range of medical devices across many therapeutic areas including fungal nail...







